Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2022 - 05 - 09 save search
University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease
Published: 2022-05-09 (Crawled : 22:00) - globenewswire.com
OLK | $22.44 1.08% 1.07% 240K
|
Manufacturing
|
| O: -1.86%
H: 0.0%
C: -9.69%
disease olink technology biomarkers
MoonLake Immunotherapeutics announces the publication of new long-term disease control data from a Phase 2b Psoriasis trial of the Nanobody® sonelokimab
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
nanobody disease control trial psoriasis publication phase 2b
Akari Presents Results from Two Preclinical Development Programs of Long-Acting PAS-Nomacopan in Geographic Atrophy (GA) Dry Age-Related Macular Degeneration and Nomacopan in Experimental Immune-Mediated Conjunctival Disease (EIC)
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
AKTX | $1.25 3.31% 3.2% 7.5K
|
Health Technology
|
| O: -0.88%
H: 2.68%
C: 0.89%
disease preclinical macular results pre-clinical
Therapeutic Solutions International Files Investigational New Drug Application for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Using JadiCell™ Universal Donor Adult Stem Cells
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: -2.43%
H: 3.73%
C: 1.66%
treatment drug disease solutions application international
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -1.74%
H: 0.98%
C: -2.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
OPK | $1.225 -2.0% -2.04% 6.1M
|
Health Technology
|
| O: -2.67%
H: 7.06%
C: -4.31%
immunotherapy health technology disease
Athira Pharma Extends Ongoing Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of Fosgonimeton (ATH-1017) for Mild to Moderate Alzheimer’s Disease
Published: 2022-05-09 (Crawled : 12:20) - biospace.com/
ATHA | $2.02 -0.98% -0.99% 78K
|
Health Technology
|
| O: -10.47%
H: 3.1%
C: -2.0%
ath-1017 ongoing pharma trials label disease alzheimer’s alzheimer's fosgonimeton
Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022
Published: 2022-05-09 (Crawled : 12:20) - biospace.com/
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: -1.23%
H: 2.14%
C: -1.25%
iw-3300 week disease
Bilirubin Blood Test Market 2022-2026 | Increasing Prevalence of Jaundice and Liver Diseases to Boost Growth | Technavio
Published: 2022-05-09 (Crawled : 09:00) - prnewswire.com
RYLPF | $20.52 3.85% 110K
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: -2.55%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -3.95%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
blood liver test growth market disease
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.